OpGen Inc (OPGN) - Company Sales

The scaling potential of OpGen, Inc. (OPGN) through the sale of hospital consumables is facing a profound management crisis and a loss of investor confidence. Corporate sales on this chart visualize this gap, where the current status equals 0.00. Technological stagnation exacerbates the situation: due to a lack of funds, the development of new infection diagnostic methods has completely ceased.

OPGN: OpGen, Inc. Revenue and Sales Volume 07/04/2022 - 08/31/2024

Analytical breakdowns for OpGen, Inc.

- market price and analyst price targets:

Market Price OpGen Corporation|OPGN - Analyst Consensus Forecast

- market capitalization indicators:

Market Valuation OpGen, Inc.|OPGN - Real Price to Acquire Entire Company

- balance sheet equity data:

Book Price of a Share OpGen|OPGN - Book Capitalization|Market Capitalization to Book Value opgen.com|OPGN - Aggregate Company Assets

- debt obligations and liquidity statistics:

- earnings and valuation multiples information:

OPGN - Net Profit|Projected Net Profit OpGen, Inc.|OPGN - P/E Multiple|Projected Price to Earnings Ratio opgen.com|OPGN - Price/Earnings to Growth Ratio|Enterprise Value to Operating Income Before Depreciation OpGen, Inc.|OPGN - Operating profit before deduction of amortization|Earnings per share for the trailing year OpGen|OPGN - Net earnings per share (EPS TTM)|Year-over-year net earnings per share change for the last twelve months opgen.com|OPGN - Earnings per share growth in current year|Projected earnings per share growth rate for next year OpGen, Inc.

- company sales and revenue statistics:

OPGN - Revenue and Sales Volume|Company Future Sales Volume OpGen Corporation|OPGN - Market Cap to Revenue|Market Cap to Expected Sales Ratio OpGen, Inc.

Comprehensive company analysis:OpGen, Inc.

OpGen, Inc. generates revenue through the sale of molecular diagnostic systems and consumables for analyzing pathogen antibiotic resistance. The dynamics of the company's commercial sales volumes reveal a hidden outflow of institutional capital: local dips in daily receipts against a backdrop of stagnating quotes signal either a critical vulnerability in the business model or the formation of an optimal entry point for a long-term investor.

Analysis of competing companies